Associations between statins and adverse events in primary prevention of cardiovascular disease: systematic review with pairwise, network, and dose-response meta-analyses
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Associations between statins and adverse events in primary prevention of cardiovascular disease: systematic review with pairwise, network, and dose-response meta-analyses
Authors
Keywords
-
Journal
BMJ-British Medical Journal
Volume -, Issue -, Pages n1537
Publisher
BMJ
Online
2021-07-15
DOI
10.1136/bmj.n1537
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Statin treatment and muscle symptoms: series of randomised, placebo controlled n-of-1 trials
- (2021) Emily Herrett et al. BMJ-British Medical Journal
- Association between CVDs and initiation and adherence to statin treatment in patients with newly diagnosed hypercholesterolaemia: a retrospective cohort study
- (2021) In Sun Ryou et al. BMJ Open
- The Safety and Tolerability of Statin Therapy in Primary Prevention in Older Adults: A Systematic Review and Meta-analysis
- (2020) Zhen Zhou et al. DRUGS & AGING
- Tackling statin intolerance with n-of-1 trials (TaSINI) in primary care: protocol for a feasibility randomised trial to increase statin adherence
- (2020) Kate Tudor et al. BMJ Open
- Incidence and Predictors of Major Adverse Cardiovascular Events in Patients With Established Atherosclerotic Disease or Multiple Risk Factors
- (2020) Benjamin Miao et al. Journal of the American Heart Association
- Efficacy and Safety of Switching from Low-Dose Statin to High-Intensity Statin for Primary Prevention in Type 2 Diabetes: A Randomized Controlled Trial
- (2020) Nuntakorn Thongtang et al. Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- Outcome of pitavastatin versus atorvastatin therapy in patients with hypercholesterolemia at high risk for atherosclerotic cardiovascular disease
- (2020) Masao Moroi et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Predicting major adverse cardiovascular events for secondary prevention: protocol for a systematic review and meta-analysis of risk prediction models
- (2020) Ralph K Akyea et al. BMJ Open
- Statin use and discontinuation in Danes age 70 and older: a nationwide drug utilisation study
- (2020) Wade Thompson et al. AGE AND AGEING
- N-of-1 Trial of a Statin, Placebo, or No Treatment to Assess Side Effects
- (2020) Frances A. Wood et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comparative effectiveness and safety of statins as a class and of specific statins for primary prevention of cardiovascular disease: A systematic review, meta-analysis and network meta-analysis of randomized trials with 94,283 participants
- (2019) Henock G Yebyo et al. AMERICAN HEART JOURNAL
- Statin Toxicity
- (2019) Natalie C. Ward et al. CIRCULATION RESEARCH
- Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials
- (2019) Jane Armitage et al. LANCET
- 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease
- (2019) Donna K. Arnett et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Translating the dose response into risk and benefit
- (2019) John B. Warren BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Trial of atorvastatin for the primary prevention of cardiovascular events in patients with rheumatoid arthritis ( TRACE RA ): A multicenter, randomized, placebo controlled trial
- (2019) George D. Kitas et al. Arthritis & Rheumatology
- A randomized unblinded trial to compare effects of intensive versus conventional lipid-lowering therapy in patients undergoing renal artery stenting
- (2019) Meng Peng et al. Journal of Cardiology
- Comparative and quantitative assessment on statin efficacy and safety: insights into inter-statin and inter-individual variability via dose- and exposure-response relationships
- (2019) Yuki Iwaki et al. Expert Opinion on Drug Metabolism & Toxicology
- Effect of different types of statins on kidney function decline and proteinuria: a network meta-analysis
- (2019) K. Esmeijer et al. Scientific Reports
- Statins for primary prevention of cardiovascular disease
- (2019) Paula Byrne et al. BMJ-British Medical Journal
- The pharmacodynamic and clinical trial evidence for statin dose
- (2018) Simon B. Dimmitt et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Intensive Treat-to-Target Statin Therapy in High-Risk Japanese Patients With Hypercholesterolemia and Diabetic Retinopathy: Report of a Randomized Study
- (2018) Hiroshi Itoh et al. DIABETES CARE
- Efficacy and safety of fixed-dose combination therapy with gemigliptin (50 mg) and rosuvastatin compared with monotherapy in patients with type 2 diabetes and dyslipidaemia (BALANCE): A multicentre, randomized, double-blind, controlled, phase 3 trial
- (2018) Ji Cheol Bae et al. DIABETES OBESITY & METABOLISM
- Assessing statin effects on cardiovascular pathways in HIV using a novel proteomics approach: Analysis of data from INTREPID, a randomized controlled trial
- (2018) Mabel Toribio et al. EBioMedicine
- Finding the Balance Between Benefits and Harms When Using Statins for Primary Prevention of Cardiovascular Disease
- (2018) Henock G. Yebyo et al. ANNALS OF INTERNAL MEDICINE
- Statin Use and the Risk of Cataracts: A Systematic Review and Meta‐Analysis
- (2017) Shandong Yu et al. Journal of the American Heart Association
- Statins for Prevention of Cardiovascular Disease in Adults
- (2016) Roger Chou et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The nocebo effect in the context of statin intolerance
- (2016) Jonathan A. Tobert et al. Journal of Clinical Lipidology
- Why do people not take life-saving medications? The case of statins
- (2016) Salim Yusuf LANCET
- Interpretation of the evidence for the efficacy and safety of statin therapy
- (2016) Rory Collins et al. LANCET
- Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease
- (2016) Salim Yusuf et al. NEW ENGLAND JOURNAL OF MEDICINE
- Methods for meta-analysis of pharmacodynamic dose–response data with application to multi-arm studies of alogliptin
- (2016) Oliver Langford et al. STATISTICAL METHODS IN MEDICAL RESEARCH
- Impact of statin related media coverage on use of statins: interrupted time series analysis with UK primary care data
- (2016) Anthony Matthews et al. BMJ-British Medical Journal
- Impact of statin related media coverage on use of statins: interrupted time series analysis with UK primary care data
- (2016) Anthony Matthews et al. BMJ-British Medical Journal
- Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management
- (2015) Erik S. Stroes et al. EUROPEAN HEART JOURNAL
- Differential Effects of Atorvastatin and Pitavastatin on Inflammation, Insulin Resistance, and the Carotid Intima-Media Thickness in Patients with Dyslipidemia
- (2015) Akihiro Nakagomi et al. Journal of Atherosclerosis and Thrombosis
- Implications of lower risk thresholds for statin treatment in primary prevention: Analysis of CPRD and simulation modelling of annual cholesterol monitoring
- (2015) Emily McFadden et al. PREVENTIVE MEDICINE
- A systematic review of statin-induced muscle problems in clinical trials
- (2014) Harsha V. Ganga et al. AMERICAN HEART JOURNAL
- Unintended effects of statins from observational studies in the general population: systematic review and meta-analysis
- (2014) Ana Filipa Macedo et al. BMC Medicine
- Differences Between Rosuvastatin and Atorvastatin in Lipid-Lowering Action and Effect on Glucose Metabolism in Japanese Hypercholesterolemic Patients With Concurrent Diabetes
- (2014) Hisao Ogawa et al. CIRCULATION JOURNAL
- Comparison of the Lipid-Lowering Effects of Pitavastatin 4 mg Versus Pravastatin 40 mg in Adults With Primary Hyperlipidemia or Mixed (Combined) Dyslipidemia: A Phase IV, Prospective, US, Multicenter, Randomized, Double-blind, Superiority Trial
- (2014) Craig A. Sponseller et al. CLINICAL THERAPEUTICS
- An assessment by the Statin Muscle Safety Task Force: 2014 update
- (2014) Robert S. Rosenson et al. Journal of Clinical Lipidology
- An assessment by the Statin Liver Safety Task Force: 2014 update
- (2014) Harold Bays et al. Journal of Clinical Lipidology
- A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis
- (2014) M. A. Puhan et al. BMJ-British Medical Journal
- A graphical tool for locating inconsistency in network meta-analyses
- (2013) Ulrike Krahn et al. BMC Medical Research Methodology
- Comparative Tolerability and Harms of Individual Statins
- (2013) Huseyin Naci et al.
- Should people at low risk of cardiovascular disease take a statin?
- (2013) J. D. Abramson et al. BMJ-British Medical Journal
- Effect of Statins on Skeletal Muscle Function
- (2012) Beth A. Parker et al. CIRCULATION
- Understanding Statin Use in America and Gaps in Patient Education (USAGE): An internet-based survey of 10,138 current and former statin users
- (2012) Jerome D. Cohen et al. Journal of Clinical Lipidology
- Pitavastatin shows greater lipid-lowering efficacy over 12 weeks than pravastatin in elderly patients with primary hypercholesterolaemia or combined (mixed) dyslipidaemia
- (2012) Steen Stender et al. European Journal of Preventive Cardiology
- Network meta-analysis, electrical networks and graph theory
- (2012) Gerta Rücker Research Synthesis Methods
- Comparative efficacy of pitavastatin and simvastatin in high-risk patients: a randomized controlled trial
- (2011) Mats Eriksson et al. ADVANCES IN THERAPY
- Randomized Head-to-Head Comparison of Pitavastatin, Atorvastatin, and Rosuvastatin for Safety and Efficacy (Quantity and Quality of LDL)
- (2011) Keijiro Saku et al. CIRCULATION JOURNAL
- Hepatotoxicity associated with statins: Reports of idiosyncratic liver injury post-marketing
- (2011) Einar Björnsson et al. JOURNAL OF HEPATOLOGY
- Adverse events associated with individual statin treatments for cardiovascular disease: an indirect comparison meta-analysis
- (2011) M. Alberton et al. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
- Effect of Lipid Lowering With Rosuvastatin on Progression of Aortic Stenosis
- (2010) Kwan Leung Chan et al. CIRCULATION
- Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials
- (2010) Naveed Sattar et al. LANCET
- Fitting Emax models to clinical trial dose-response data
- (2010) Simon Kirby et al. PHARMACEUTICAL STATISTICS
- Checking consistency in mixed treatment comparison meta-analysis
- (2010) S. Dias et al. STATISTICS IN MEDICINE
- Outlier and influence diagnostics for meta-analysis
- (2010) Wolfgang Viechtbauer et al. Research Synthesis Methods
- Statins for Asymptomatic Middle Cerebral Artery Stenosis: The Regression of Cerebral Artery Stenosis Study
- (2009) Vincent C.T. Mok et al. CEREBROVASCULAR DISEASES
- Long-term persistence with statin therapy: A nationwide register study in Finland
- (2009) Arja Helin-Salmivaara et al. CLINICAL THERAPEUTICS
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. PLOS MEDICINE
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
- (2008) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now